|
|
|
|
|
|
|
|
|
|
|
|
|
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
This schedule contains summary information extracted from the Ampersand Medical
Corporation Consolidated Balance Sheet (Unaudited) for June 30, 2000 and the
Consolidated Statement of Operations (Unaudited) for the Six-Months ended June
30, 2000 and is qualifed in its entirety by reference to such financial
statements.
</LEGEND>
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 6-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-END> JUN-30-2000
<CASH> 56
<SECURITIES> 0
<RECEIVABLES> 1,346
<ALLOWANCES> 21
<INVENTORY> 204
<CURRENT-ASSETS> 2,747
<PP&E> 367
<DEPRECIATION> 87
<TOTAL-ASSETS> 4,951
<CURRENT-LIABILITIES> 1,799
<BONDS> 0
0
0
<COMMON> 30
<OTHER-SE> 12,054
<TOTAL-LIABILITY-AND-EQUITY> 4,951
<SALES> 541
<TOTAL-REVENUES> 541
<CGS> 349
<TOTAL-COSTS> 349
<OTHER-EXPENSES> 3,973
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 30
<INCOME-PRETAX> (3,785)
<INCOME-TAX> 0
<INCOME-CONTINUING> (3,785)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (3,785)
<EPS-BASIC> (0.15)
<EPS-DILUTED> (0.15)
</TABLE>
|
|